Rentschler Biopharma appoints Mark Caswell as Vice President, Site Head for US Facility
August 18, 2022 09:03 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., Aug. 18, 2022 (GLOBE NEWSWIRE) -- Rentschler Biopharma, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma adds highly experienced executive to team and provides update on progress at Rentschler ATMP
June 13, 2022 10:00 ET
|
Rentschler Biopharma SE
Company hires Kassim Kolia, as Vice President, Business Development to grow cell and gene therapy businessStevenage ATMP site projected to be client ready for process development in late 2022 ...
Rentschler Biopharma reports strong growth and continues hiring at all three sites
December 20, 2021 07:00 ET
|
Rentschler Biopharma SE
Over 300 new team members in 2021, additional new positions planned at all sitesRentschler Biopharma again named one of “most attractive employers” in Germany by the F.A.Z. Institute and awarded first...
Rentschler Biopharma donates 50,000 Euros to support construction of the Albert Einstein Discovery Center in Ulm
September 22, 2021 07:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and ULM, Germany, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is...
Rentschler Biopharma breaks ground at new U.S. production site in greater Boston
August 12, 2021 08:00 ET
|
Rentschler Biopharma SE
New facility, adjacent to existing Milford, MA site, to significantly expand cGMP manufacturing capacity, accelerating clinical and commercial supply of essential biopharmaceuticalsSite will employ...
Rentschler Biopharma appoints Dr. Martin Kessler as Chief Executive Officer of U.S. Subsidiary and as Senior Vice President Transformation
March 31, 2021 04:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany and MILFORD, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals,...
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
March 22, 2021 05:00 ET
|
Rentschler Biopharma SE
Leukocare joins Rentschler Biopharma in the U.S., facilitating integrated alliance capabilities and enhanced service for North American clientsClient-focused approach and integration of best-in-class...
Rentschler Biopharma establishes Center of Excellence for cell and gene therapy in the UK
February 11, 2021 04:10 ET
|
Rentschler Biopharma SE
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansionCenter of Excellence to address the gap in capacity...
Rentschler Biopharma to build new cell and gene therapy capabilities in the UK
February 11, 2021 04:00 ET
|
Rentschler Biopharma SE; The Cell and Gene Therapy Catapult
Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in StevenageAgreement confirms UK’s global attractiveness for...
Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
January 11, 2021 08:00 ET
|
LEUKOCARE AG
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Germany-based formulation development specialist Leukocare opens US presence to support local...